1
Clinical Trials associated with Maternal vaginal microbiota(PPD)Exposure to Vaginal Microbiome in C-section Infants at High-risk for Allergies - A Pilot Study
The purpose of this research study is to assess at how differences in the microbiome (naturally occurring bacteria) of a baby may protect, or put a baby at risk, for allergic problems. The microbiome refers to the thousands of bacteria and molds that live in and on our bodies. The microbiome plays an important role in our health. Differences in the microbiome can affect our immune system in ways that might make some people more likely to get allergies and asthma.
Early life events and exposures are very important for establishing the human microbiome. The newborn baby's microbiome changes very quickly during the first weeks and months of life. There is information that suggests C-section birth is associated with higher risk of certain diseases, including allergies and asthma. Some researchers think one reason for this is that passing through the mother's vaginal canal during birth exposes the baby to bacteria that promote healthy immune system development, something that C-section babies don't get. Transferring these potentially beneficial vaginal bacteria to C-section babies may help prevent some diseases later.
100 Clinical Results associated with Maternal vaginal microbiota(PPD)
100 Translational Medicine associated with Maternal vaginal microbiota(PPD)
100 Patents (Medical) associated with Maternal vaginal microbiota(PPD)
100 Deals associated with Maternal vaginal microbiota(PPD)